Dentin Matrix Protein 1 (DMP1) for use in pharmaceutical compositions

No full text

Patent (Patents)

Castronovo, Vincenzo; Bellahcene, Akeila; Pirotte, Sophie

2012

Permalink
https://hdl.handle.net/2268/226213

Files (0)Send to Details Statistics Bibliography Similar publications

Files

Full Text

No document available.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] The present invention refers to Dentin Matrix Protein 1 (DMP1) or a polynucleotide encoding Dentin Matrix Protein 1, for use for reducing and/or preventing angiogenesis and for use in the preventive and/or therapeutic treatment of angiogenesis-related diseases.

Disciplines :

Laboratory medicine & medical technology

Inventor :

Castronovo, Vincenzo ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie générale et cellulaire

Bellahcene, Akeila ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Labo de recherche sur les métastases

Pirotte, Sophie

Language :

English

Title (54) :

Dentin Matrix Protein 1 (DMP1) for use in pharmaceutical compositions

Publication date (43-45) :

02 February 2012

Filing date (22) :

30 July 2010

Patent/publication number (10-11) :

2012/013249

Patent status (13) :

Priority number (30) :

PCT/EP2010/061154

International classification (IPC) (51) :

A61K 38/17, A61P 37/00, A61P 35/00, A61P 17/06, A61P 19/02, A61P 19/00, A61P 9/10, A61P 15/00, A61P 17/02, A61P 27/06, A61P 27/00

European classification (ECLA) (52) :

A61K 38/9709

Applicant (71) :

ULg - Université de Liège

Publication organism (19) :

Worl Intellectual Property Organization

Available on ORBi :

since 03 July 2018

Statistics

Number of views

58 (3 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics